European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011)

被引：194

作者：

Matthes-Martin, S. ^{[2
]}

Feuchtinger, T. ^{[3
]}

Shaw, P. J. ^{[4
]}

Engelhard, D. ^{[5
]}

Hirsch, H. H. ^{[6
]}

Cordonnier, C. ^{[7
,8
]}

Ljungman, P. ^{[1
,9
]}

机构：

[1] Karolinska Univ Hosp, Dept Hematol, S-141861 Stockholm, Sweden

[2] Med Univ, Dept Pediat, Stem Cell Transplantat Unit, St Anna Childrens Hosp, Vienna, Austria

[3] Univ Tubingen Hosp, Dept Pediat, Tubingen, Germany

[4] Childrens Hosp Westmead, Oncol Unit, Sydney, NSW, Australia

[5] Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel

[6] Univ Basel Hosp, Dept Virol, CH-4031 Basel, Switzerland

[7] Hop Henri Mondor, Assistance Publ Hop Paris, Dept Hematol, F-94010 Creteil, France

[8] Univ Paris Est Creteil, Creteil, France

[9] Karolinska Inst, Dept Med Huddinge, Sect Hematol, Stockholm, Sweden

来源：

TRANSPLANT INFECTIOUS DISEASE | 2012年 / 14卷 / 06期

关键词：

human adenovirus; leukemia; stem cell; guidelines; REAL-TIME PCR; BONE-MARROW-TRANSPLANTATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; POLYMERASE-CHAIN-REACTION; PERIPHERAL-BLOOD; PEDIATRIC-PATIENTS; T-CELLS; IMMUNE RECONSTITUTION; REDUCED-INTENSITY;

D O I：

10.1111/tid.12022

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Human adenovirus (HAdV) infections are increasingly recognized as important pathogens in immunocompromised hosts, especially in patients with severely suppressed T-cell function. The 4th European Conference of Infections in Leukemia (ECIL-4) has developed evidence-based guidelines for diagnosis and management of HAdV infections. The risk for HAdV-associated disease is increased in children, and risk factors for HAdV disease are T-cell depletion, unrelated and cord blood hematopoietic stem cell transplantation, graft-versus-host disease grades IIIIV, and lymphopenia. The recommended technique for monitoring of high-risk patients is quantitative polymerase chain reaction. Cidofovir is the most used antiviral therapy, although no controlled study has been performed. HAdV-specific T-cell therapy is in development.

引用

页码：555 / 563

页数：9

共 13 条

[1] European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN
Engelhard, D.
Mohty, B.
de la Camara, R.
Cordonnier, C.
Ljungman, P.
TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (03) : 219 - 232
[2] Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus
Hirsch, Hans H.
Martino, Rodrigo
Ward, Katherine N.
Boeckh, Michael
Einsele, Hermann
Ljungman, Per
CLINICAL INFECTIOUS DISEASES, 2013, 56 (02) : 258 - 266
[3] Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)
Averbuch, Diana
Cordonnier, Catherine
Livermore, David M.
Mikulska, Malgorzata
Orasch, Christina
Viscoli, Claudio
Gyssens, Inge C.
Kern, Winfried V.
Klyasova, Galina
Marchetti, Oscar
Engelhard, Dan
Akova, Murat
HAEMATOLOGICA, 2013, 98 (12) : 1836 - 1847
[4] European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update
J Maertens
O Marchetti
R Herbrecht
O A Cornely
U Flückiger
P Frêre
B Gachot
W J Heinz
C Lass-Flörl
P Ribaud
A Thiebaut
C Cordonnier
Bone Marrow Transplantation, 2011, 46 : 709 - 718
[5] European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 Update
Maertens, J.
Marchetti, O.
Herbrecht, R.
Cornely, O. A.
Flueckiger, U.
Frere, P.
Gachot, B.
Heinz, W. J.
Lass-Floerl, C.
Ribaud, P.
Thiebaut, A.
Cordonnier, C.
BONE MARROW TRANSPLANTATION, 2011, 46 (05) : 709 - 718
[6] ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients
Cesaro, Simone
Dalianis, Tina
Rinaldo, Christine Hanssen
Koskenvuo, Minna
Pegoraro, Anna
Einsele, Hermann
Cordonnier, Catherine
Hirsch, Hans H.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (01) : 12 - 21
[7] Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines
Styczynski, Jan
van der Velden, Walter
Fox, Christopher P.
Engelhard, Dan
de la Camara, Rafael
Cordonnier, Catherine
Ljungman, Per
HAEMATOLOGICA, 2016, 101 (07) : 803 - 811
[8] Patient, Virus, and Treatment-Related Risk Factors in Pediatric Adenovirus Infection after Stem Cell Transplantation: Results of a Routine Monitoring Program
Mynarek, Martin
Ganzenmueller, Tina
Mueller-Heine, Annika
Mielke, Christopher
Gonnermann, Andrea
Beier, Rita
Sauer, Martin
Eiz-Vesper, Britta
Kohstall, Ute
Sykora, Karl-Walter
Heim, Albert
Maecker-Kolhoff, Britta
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : 250 - 256
[9] Hematopoietic Stem Cell Transplantation for Treatment of Patients with Leukemia Concomitant with Active Tuberculosis Infection
Liu, Mingjuan
Yang, Caie
Liu, Lihui
Shi, Bing
Hu, Wenqing
Ye, Liping
Zhang, Yongqing
MEDICAL SCIENCE MONITOR, 2014, 20 : 2484 - 2488
[10] Diagnosis and treatment for the early stage of cytomegalovirus infection during hematopoietic stem cell transplantation
Cui, Jiaqi
Zhao, Kui
Sun, Yanling
Wen, Ruijuan
Zhang, Xiangzhong
Li, Xudong
Long, Bing
FRONTIERS IN IMMUNOLOGY, 2022, 13

← 1 2 →